Back
Design Therapeutics Stock Price Chart
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
DSGN
Design Therapeutics
Last Price:
$4.64
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder that's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing selling pressure, which indicates risk of future bearish movement.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.87 | Sell |
| 20-day SMA: | 4.86 | Sell |
| 50-day SMA: | 4.8 | Sell |
| 200-day SMA: | 4.97 | Sell |
| 8-day EMA: | 1.03 | Buy |
| 20-day EMA: | 0.44 | Buy |
| 50-day EMA: | 0.18 | Buy |
| 200-day EMA: | 0.05 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 46.54 | Sell |
| Chaikin Money Flow: | -78977 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.25 - 5.09) | Sell |
| Bollinger Bands (100): | (4.61 - 6.17) | Sell |
Design Therapeutics Technical Analysis
| Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.64 while DSGN 8-day simple moving average is 4.87, which is a Sell signal.
-
The stock price of DSGN is 4.64 while Design Therapeutics 20-day SMA is 4.86, which makes it a Sell.
-
Design Therapeutics 50-day simple moving average is 4.80 while DSGN share price is 4.64, making it a Sell technically.
-
DSGN stock price is 4.64 and Design Therapeutics 200-day simple moving average is 4.97, creating a Sell signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
43
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a SellThe current Design Therapeutics [DSGN] share price is $4.64. The Score for DSGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
263.4M
Price in USD:
4.64
Share Volume:
102.4K
Design Therapeutics 52-Week Range
52-Week High:
7.77
52-Week Low:
2.91
Sell
43
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?The Design Therapeutics stock price is 4.64 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.64 while DSGN 8-day exponential moving average is 1.03, which is a Buy signal.
-
The stock price of DSGN is 4.64 while Design Therapeutics 20-day EMA is 0.44, which makes it a Buy.
-
Design Therapeutics 50-day exponential moving average is 0.18 while DSGN share price is 4.64, making it a Buy technically.
-
DSGN stock price is 4.64 and Design Therapeutics 200-day simple moving average is 0.05, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.31 per share, and an increase next year of $0.09 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is 0.37, suggesting Design Therapeutics is a Buy
-
Design Therapeutics Relative Strength Index (RSI) is 46.54, which suggest Design Therapeutics is oversold
-
The Bollinger Bands (25) for Design Therapeutics is (4.25 - 5.09), which suggest Design Therapeutics is a Sell
-
The Bollinger Bands (100) for Design Therapeutics is (4.61 - 6.17), which suggest Design Therapeutics is a Sell
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.